Human Monoclonals International

Human Monoclonals International (HMI) is a biotechnology company specializing in the discovery and development of fully human monoclonal antibodies for infectious diseases and biodefense. Founded by Dr. James Larrick and operating within the Panorama Research Institute incubator, the company utilizes a proprietary platform to isolate antibodies from human donors who have naturally cleared or resisted specific pathogens. This approach aims to produce highly potent and safe therapeutic candidates with minimal immunogenicity. HMI's lead programs include HumaRAX for anthrax and HumaRAB for rabies, both of which have been developed in collaboration with government and academic partners. The company's business model focuses on early-stage discovery and proof-of-concept before seeking strategic partners for late-stage clinical development and commercialization.